Furthermore, many studies also demonstrated that the soluble form of B7-H3 (sB7-H3) was aberrant in malignant tumors and correlated with the poor prognosis, and sB7-H3 could be the potential diagnostic and therapeutic target in tumor diseases [9–11]. Here, CD276 is linked to neoplasm.